Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

166
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
166
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation01:24

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

894
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
894
Multicompartment Models: Overview01:14

Multicompartment Models: Overview

353
Multicompartment models are mathematical constructs that depict how drugs are distributed and eliminated within the body. They segment the body into several compartments, symbolizing various physiological or anatomical areas connected through drug transfer processes such as absorption, metabolism, distribution, and elimination.
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
353
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

339
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
339
Multi-input and Multi-variable systems01:22

Multi-input and Multi-variable systems

253
Cruise control systems in cars are designed as multi-input systems to maintain a driver's desired speed while compensating for external disturbances such as changes in terrain. The block diagram for a cruise control system typically includes two main inputs: the desired speed set by the driver and any external disturbances, such as the incline of the road. By adjusting the engine throttle, the system maintains the vehicle's speed as close to the desired value as possible.
In the absence of...
253
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

1.1K
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Selecting medical research data platforms for translational biomedical research: a five-tier overview and requirement-weighted assessment framework.

Frontiers in digital health·2026
Same author

Screening for Alzheimer's disease in the community using an AI-driven screening platform: design of the PREDICTOM study.

The journal of prevention of Alzheimer's disease·2026
Same author

[<sup>177</sup>Lu]Lu-DOTATATE Population Pharmacokinetics and Dosimetry Modeling for Adolescent and Adult Patients with Somatostatin Receptor-Positive Gastroenteropancreatic Neuroendocrine Tumors.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same author

Data-driven clinical decision support tool for diagnosing mild cognitive impairment in Parkinson's disease.

NPJ Parkinson's disease·2026
Same author

An Interactive Brain Atlas of Knowledge.

bioRxiv : the preprint server for biology·2025
Same author

Dementia Care Research and Psychosocial Factors.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025

Related Experiment Video

Updated: Nov 14, 2025

Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.5K

Variational Autoencoder Modular Bayesian Networks for Simulation of Heterogeneous Clinical Study Data.

Luise Gootjes-Dreesbach1, Meemansa Sood2,3, Akrishta Sahay2

  • 1UCB Pharma (UCB Celltech Ltd.), Slough, United Kingdom.

Frontiers in Big Data
|March 11, 2021
PubMed
Summary

This study introduces a novel machine learning method, Variational Autoencoder Modular Bayesian Network (VAMBN), to generate realistic virtual patients from siloed clinical data. This approach enhances data privacy and facilitates clinical trial design.

Keywords:
Bayesian Networksautoencodersclinical study simulationlongitudinal datatime series data

More Related Videos

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

16.0K
Basics of Multivariate Analysis in Neuroimaging Data
06:35

Basics of Multivariate Analysis in Neuroimaging Data

Published on: July 24, 2010

17.1K

Related Experiment Videos

Last Updated: Nov 14, 2025

Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.5K
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

16.0K
Basics of Multivariate Analysis in Neuroimaging Data
06:35

Basics of Multivariate Analysis in Neuroimaging Data

Published on: July 24, 2010

17.1K

Area of Science:

  • Biomedical Big Data Analytics
  • Machine Learning in Healthcare
  • Clinical Data Management

Background:

  • Biomedical research faces challenges due to data silos, hindering progress.
  • Existing federated learning methods are limited to data of the same format.
  • Accessing and understanding diverse, separately designed clinical studies remains difficult.

Purpose of the Study:

  • To develop a machine learning approach for learning generative models of longitudinal clinical study data.
  • To address limitations in data sharing caused by legal and ethical constraints.
  • To enable the simulation of realistic virtual patients from siloed datasets.

Main Methods:

  • Proposed a novel machine learning approach: Variational Autoencoder Modular Bayesian Network (VAMBN).
  • VAMBN learns a generative model for longitudinal clinical data.
  • The model accounts for limited sample sizes, numerous variables, varying scales, and missing values.

Main Results:

  • VAMBN successfully simulates virtual patients with high realism.
  • Theoretical guarantees on data privacy are provided.
  • The method enables simulation of counterfactual scenarios.

Conclusions:

  • VAMBN offers a viable solution for overcoming data silos in biomedical research.
  • The approach facilitates secure data sharing and improves clinical trial design.
  • This method supports the mining and understanding of diverse clinical study data.